Cary L Majors sold $3.2M of STE
SVP and President, Healthcare at STERIS plc. 12,828 shares at an average of $250.08, traded May 20, 2025, filed May 22, 2025.
Score components
- +15RoleOfficer
- +25Trade size$3.2M at market
- +20Share of holdings soldSold 53% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -3.1%, 3m +1.8%, 6m +5.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-027284, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 20, 2025 | MOption exercise Ordinary Shares | +12,828 | $147.05 | $1.9M | 24,200 | May 22, 2025 |
| May 20, 2025 | SOpen-market sale Ordinary Shares | -8,247 | $249.73 | $2.1M | 15,953 | May 22, 2025 |
| May 20, 2025 | SOpen-market sale Ordinary Shares | -4,581 | $250.71 | $1.1M | 11,372 | May 22, 2025 |
| May 20, 2025 | MOption exercise Employee Stock Option (right to buy)derivative | -12,828 | $0.00 | $0 | 0 | May 22, 2025 |
Related signals
Other insiders at STERIS plc and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 29Weak | STEsell STERIS plc | Mohsen Sohi director | $957k 4,058 shares | -14% | |
| 24Weak | STERIS plc | John Adam Zangerle Sr. VP, Gen Counsel, and Sec. | $297k 1,419 shares | -4% | |
| 44Moderate | STERIS plc | Daniel A Carestio President and CEO | $947k 4,428 shares | -7% | |
| 29Weak | STERIS plc | Richard C Breeden director | $310k 1,481 shares | -4% | |
| 41Moderate | STEsell STERIS plc | Cynthia L Feldmann director | $735k 3,098 shares | -81% | |
| 50Moderate | STERIS plc | Julia Madsen Sr. VP and GM, Life Sciences | $1.3M 5,008 shares | -37% | |
| 57Moderate | STERIS plc | Renato Tamaro V.P. & Corporate Treasurer | $1.3M 5,036 shares | -47% | |
| 50Moderate | STERIS plc | John Adam Zangerle Sr. VP, Gen Counsel, and Sec. | $4.0M 15,000 shares | -31% | |
| 11Weak | STERIS plc | Daniel A Carestio President and CEO | $38k 159 shares | -0% | |
| 54Moderate | STERIS plc | Renato Tamaro V.P. & Corporate Treasurer | $799k 3,204 shares | -31% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.